BioSpace News Archive

Business

Cracks Appear in Moderna’s Rapid Ascension as Vaccine Forecast Lowered

Moderna reported its third-quarter earnings, and since it currently only has one commercial product, its COVID-19 vaccine, that was the financial focus.

November 5, 2021
·
3 min read
·
Mark Terry
FDA

Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug

Ardelyx, Inc. is lacing up the gloves and preparing to wade into the ring with the U.S. Food and Drug Administration to dispute the July rejection of its chronic kidney disease drug, tenapanor.

November 5, 2021
·
3 min read
·
Alex Keown
Biotech Bay

Two VCs Raise Over $1 Billion for New Health Care Innovation

The life sciences industry might just be filling a bit richer this week as two major venture capital firms announced the closing of new funds.

November 5, 2021
·
2 min read
·
Heather McKenzie
Business

Alphabet Introduces New AI Drug Discovery Company

Isomorphic Laboratories has expressed plans to foray into drug discovery and development by tapping into the technology of its sister company DeepMind.

November 5, 2021
·
2 min read
·
Vanessa Doctor, RN
Policy

U.S. Government Cancels Contract with Embattled Emergent BioSolutions

The U.S. government canceled a contract with Maryland-based Emergent BioSolutions, which earlier in the year ruined about 15 million doses of the Johnson & Johnson COVID-19 vaccine.

November 5, 2021
·
4 min read
·
Mark Terry
Drug Development

Clinical Catch-Up: November 1-5

The first week of November was marked by numerous clinical trial announcements. Here’s a look.

November 5, 2021
·
13 min read
·
Mark Terry
FDA

FDA Action Alert: Liquidia, Adamis and BioMarin

Mid-November is a relatively quiet period for the U.S. Food and Drug Administration in terms of its scheduled PDUFA dates. Read on for more.

November 5, 2021
·
3 min read
·
Mark Terry
6 Reasons You Should Consider a Pharmaceutical Career

The pharma industry is a very lucrative field to invest your efforts in. In this article, we will cover the reasons many people love working in the pharmaceutical industry.

November 5, 2021
·
4 min read
·
Alina Zahid
Drug Development

With Positive Results in Fabry Disease, Sangamo Heading for Phase III

Sangamo Therapeutics announced positive preliminary findings from its ongoing Phase I/II STAAR clinical trial in Fabry disease.

November 5, 2021
·
2 min read
·
Vanessa Doctor, RN
Drug Development

Pfizer to Seek EUA for COVID-19 Antiviral with 89% Efficacy

Pfizer plans to seek Emergency Use Authorization for an antiviral COVID-19 treatment following an interim analysis of Phase II/III data that show statistically and clinically meaningful results.

November 5, 2021
·
3 min read
·
Alex Keown